Cartesian Therapeutics
Clinical trials sponsored by Cartesian Therapeutics, explained in plain language.
-
Could a One-Time cell treatment tame rare muscle diseases?
Disease control Recruiting nowThis study tests a new treatment called Descartes-08 for people with dermatomyositis or antisynthetase syndrome, two rare diseases that cause muscle inflammation and weakness. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune syste…
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
Could a single mRNA treatment ease myasthenia gravis symptoms?
Disease control Recruiting nowThis phase 3 study tests an experimental therapy called Descartes-08 in 100 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The treatment uses mRNA to reprogram a patient's own immune cells to target and calm the overactive immune response. The…
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New cell therapy trial offers hope for young people with rare autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment called Descartes-08 in 50 children, adolescents, and young adults with four autoimmune diseases: lupus, vasculitis, myasthenia gravis, and dermatomyositis. The goal is to see if it is safe and can control moderate disease symptoms. Participants re…
Phase: PHASE1, PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:57 UTC